- Home
- ODYS vs CSBR Comparison
ODYS vs CSBR Comparison
Compare ODYS & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODYS
- CSBR
- Stock Information
- Founded
- ODYS N/A
- CSBR 1985
- Country
- ODYS Israel
- CSBR United States
- Employees
- ODYS N/A
- CSBR N/A
- Industry
- ODYS
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ODYS
- CSBR Health Care
- Exchange
- ODYS NYSE
- CSBR Nasdaq
- Market Cap
- ODYS 107.4M
- CSBR 113.0M
- IPO Year
- ODYS N/A
- CSBR 1986
- Fundamental
- Price
- ODYS $5.30
- CSBR $7.86
- Analyst Decision
- ODYS Strong Buy
- CSBR Strong Buy
- Analyst Count
- ODYS 1
- CSBR 1
- Target Price
- ODYS $10.00
- CSBR $12.00
- AVG Volume (30 Days)
- ODYS 26.9K
- CSBR 40.0K
- Earning Date
- ODYS 03-28-2025
- CSBR 03-11-2025
- Dividend Yield
- ODYS N/A
- CSBR N/A
- EPS Growth
- ODYS N/A
- CSBR N/A
- EPS
- ODYS N/A
- CSBR 0.46
- Revenue
- ODYS $3,964,000.00
- CSBR $58,591,000.00
- Revenue This Year
- ODYS N/A
- CSBR $15.11
- Revenue Next Year
- ODYS N/A
- CSBR $7.80
- P/E Ratio
- ODYS N/A
- CSBR $17.32
- Revenue Growth
- ODYS 30.70
- CSBR 19.03
- 52 Week Low
- ODYS $5.45
- CSBR $3.60
- 52 Week High
- ODYS $10.80
- CSBR $11.99
- Technical
- Relative Strength Index (RSI)
- ODYS N/A
- CSBR 42.25
- Support Level
- ODYS N/A
- CSBR $7.74
- Resistance Level
- ODYS N/A
- CSBR $8.86
- Average True Range (ATR)
- ODYS 0.00
- CSBR 0.75
- MACD
- ODYS 0.00
- CSBR 0.03
- Stochastic Oscillator
- ODYS 0.00
- CSBR 41.26
About ODYS ODYSIGHT AI INC
Odysight ai Inc is engaged in the development, production, and marketing of innovative Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) technologies, providing visual sensing and AI-based video analytics solutions for critical systems in the aviation, maritime, industrial non-destructing-testing industries, transportation, and energy industries.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.